The joint effect of apolipoprotein E ε4 and MRI findings on lower- extremity function and decline in cognitive function

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 55, Issue 2, 2000, Pages

  Carmelli, Dorit ^a   DeCarli, Charles ^b   Swan, Gary E ^a   Kelly Hayes, Maggie ^c   Wolf, Philip A ^c   Reed, Terry ^d   Guralnik, Jack M ^e  

^a SRI INTERNATIONAL   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4;

AGED; ARTICLE; BRAIN SCINTISCANNING; BRAIN SIZE; CEREBROSPINAL FLUID; COGNITIVE DEFECT; FUNCTION TEST; GAIT; HUMAN; LEG; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; WHITE MATTER;

EID: 0034102992     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/55.2.M103     Document Type: Article

References (44)

1. Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med. 1995;332:556-561.
2. Swan GE, Carmelli D, LaRue A. Performance on the Digit Symbol Substitution test and 5-year mortality in the Western Collaborative Group Study. Am J Epidemiol. 1995;141:32-40.
3. Guralnik JM, LaCroix AZ, Abbott RD, et al. Maintaining mobility in late life. I. Demographic characteristics and chronic conditions. Am J Epidemiol. 1993;137:845-857.
4. Boult C, Kane RL, Louis TA, Boult L, McCaffrey D. Chronic conditions that lead to functional limitation in the elderly. J Gerontol Med Sci. 1994; 49:M28-M36.
5. Vaccarino V, Berkman LF, Mendes de Leon CF, Seeman TE, Horwitz RI, Krumholtz HM. Functional disability before myocardial infarction in the elderly as a determinant of infarction severity and postinfarction mortality. Arch Intern Med. 1997;157:2196-2204.
6. Miles T. Population-based, genetically informative sample for studies of physical frailty and aging: black elderly twin study. Hum Biol. 1997;69: 107-120.
7. Fried LP, Guralnik JM. Disability in older adults: evidence regarding significance, etiology, and risk. J Am Geriatr Soc. 1997;45:92-100.
8. Chartier-Harlin MC, Parfitt M, Legrain S, et al. Apolipoprotein E, ε4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet. 1994;3:568-574.
9. Levy-Lahad E, Bird TD. Genetic factors in Alzheimer's disease: a review of recent advances. Ann Neurol. 1996;40:829-849.
10. Van Duijn CM, De Knijff P, Cruts M, et al. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nature Genet. 1994;7:74-78.
11. Tierney MC, Szalai JP, Snow WG, et al. A prospective study of the clinical utility of ApoE genotype in the prediction of outcome in patients with memory impairment. Neurology. 1996;46:149-154.
12. Longstreth WT, Manolio TA, Arnold A, et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke. 1996;27:1274-1282.
13. Tell GS, Lefkowitz DS, Diehr P, Elster AD. Relationship between balance and abnormalities in cerebral magnetic resonance imaging in older adults. Arch Neurol. 1998;55:73-79.
14. Kuller LH, Shemanski L, Manolio T, et al. Relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health Study. Stroke. 1998;29:388-398.
15. Feinleib M, Garrison RJ, Fabsitz RR, et al. The NHLBI Twin Study of cardiovascular risk factors: methodology and summary of results. Am J Epidemiol. 1977;106:284-295.
16. Reed T, Quiroga J, Selby JV, et al. Concordance of ischemic heart disease in the NHLBI Twin Study after 14-18 years of follow-up. J Clin Epidemiol. 1991;44:797-805.
17. Carmelli D, DeCarli C, Swan GE, et al. Evidence for genetic variance in white-matter hyperintensity volume in normal elderly male twins. Stroke. 1998;29:1177-1181.
18. Swan GE, DeCarli C, Miller BL, et al. Association of mid-life blood pressure to late-life cognitive decline and brain morphology. Neurology. 1998;51:1-7.
19. DeCarli C, Maisog J, Murphy DGM, Teichberg D, Rapoport SI, Horowitz B. A method for quantification of brain, central and peripheral CSF volumes from magnetic resonance imaging. J Comput Assist Tomogr. 1992; 16:274-284.
20. DeCarli C, Murphy DGM, Schapiro MB, Horwitz B. Diagnostic utility of frontal and temporal lobe volumes as measured from magnetic resonance images in dementia of the Alzheimer type. Neurology. 1993;43(suppl. 2):A403-A404.
21. Murphy DGM, DeCarli C, Schapiro MB, Rapoport SI, Horwitz B. Age-related differences in volumes of subcortical nuclei, brain matter, and cerebrospinal fluid in healthy men as measured with magnetic resonance imaging. Arch Neurol. 1992;49:839-845.
22. Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol Med Sci. 1994;49:M85-M94.
23. Folstein MF, Holstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
24. Wechsler D. Manual: Wechsler Adult Intelligence Scale-Revised. New York: Psychological Corporation; 1974.
25. Eslinger PJ, Damasio AR, Benton AL. The Iowa Battery for Mental Decline. Iowa City: University of Iowa; 1984.
26. Hixon JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res. 1990;31:545-548.
27. Schachter F, Faure-Delanef L, Guenot F, et al. Genetic associations with human longevity at the ApoE and ACE loci. Nature Genet. 1994;6:29-32.
28. Efron B, Tibshirani R. Bootstrap methods for standard errors, confidence intervals and other measures of statistical accuracy. Statist Sci. 1986; 1:54-77.
29. Boone KB, Miller BL, Lesser IM, Mehringer CM, Hill E, Berman N. Cognitive deficits with white-matter lesions in healthy elderly. Arch Neurol. 1992;49:549-554.
30. De Carli C, Murphy DGM, Tranh M, et al. The effect of white-matter hyperintensity volume on brain structure, cognitive performance and cerebral metabolism of glucose in 51 healthy adults. Neurology. 1995;45: 2077-2084.
31. Schmidt H, Schmidt R, Fazekas F, et al. Apolipoprotein E ε4 allele in the normal elderly: neuropsychologic and brain MRI correlates. Clin Genet. 1996;50:293-299.
32. Schmidt H, Schmidt R, Fazekas F, et al. Apolipoprotein E polymorphism and silent microangiopathy-related cerebral damage. Results of the Austrian Stroke Prevention Study. Stroke. 1997;28:951-956.
33. Sudarsky L, Ronthal M. Gait disorders among elderly patients. Arch Neurol. 1983;40:740-743.
34. Hendrie HC, Farlow MR, Austrom MG. Foci of increased T2 signal intensity on brain MR scans of healthy elderly subjects. Am J Neuroradiol. 1989;10:703-707.
35. Baloh RW, Yeu Q, Socotch TM, Jacobson KM. White matter lesions and disequilibrium in older people. I: Case-control comparison. Arch Neurol. 1995;52:970-974.
36. Kalmijn S, Feskens EJM, Launer LJ, Kromhout D. Cerebrovascular disease, the apolipoprotein ε4 allele, and cognitive decline in a community-based study of elderly men. Stroke. 1996;27:2230-2235.
37. Hofman A, Ott A, Breteler MM, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet. 1997;349:151-154.
38. DeCarli C, Reed T, Miller BL, Wolf PA, Swan GE, Carmelli D. Impact of apolipoprotein E ε4 and vascular disease on brain morphology in men from the NHLBI Twin Study. Stroke. 1999;30:1548-1553.
39. Masliah E, Mallory M, Nianfeng G, Alford M, Veinbergs I, Roses AD. Neurodegeneration in the central nervous system of apo E-deficient mice. Exp Neurol. 1995;136:107-122.
40. Miyata M, Smith JD. Apolipoprotein E allele-specific antioxidant activity and effects of cytotoxicity by oxidative insults and β-amyloid peptides. Nature Genet. 1996;14:55-61.
41. Thomas T, Thomas G, McLendon C, Sutton T, Mullan M. β-Amyloid-mediated vasoactivity and vascular endothelial damage. Nature. 1996; 380:168-171.
42. Poirier J. Apolipoprotein E in the brain and its role in Alzheimer's disease. J Psychiatry Neurosci. 1996;21:128-134.
43. Salehi A, Dubelaar EJ, Mulder M, Swaab DF. Aggravated decrease in the activity of nucleus basalis neurons in Alzheimer's disease is apolipoprotein E-type dependent. Proc Natl Acad Sci USA. 1998;95:11445-11449.
44. DeCarli C, Grady CL, Clark CM, et al. Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matter. J Neurol Neurosurg Psychiatry. 1996;60:158-167.